Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Ixekizumab Biosimilar - Anti-IL17A mAb - Research Grade |
---|---|
Source | DrugBank DB11569 |
Species | Human |
Expression system | Mammalian cells |
Molecular weight | 146kDa |
Purity | >85% |
Buffer | PBS pH7.5 |
Delivery condition | Blue ice (+4°C) |
Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Applications | ELISA,WB |
Aliases /Synonyms | Ixekizumab,Ixekizumab,IL17A,anti-IL17A |
Reference | PX-TA1022 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG4Kappa |
Clonality | Monoclonal Antibody |
Recombinant monoclonal antibody to IL17A. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases. This product is for research use only.
Ixekizumab Biosimilar - Anti-IL17A mAb on SDS-PAGE under reducing (left figure) and non-reducing (right figure) conditions. The gel was stained overnight with Coomassie Blue. The purity of the antibody is superior than 90 %.
Immobilized IL17A, C-His, recombinant protein (cat. No.PX-P5780) at 0.5µg/mL (100µL/well) can bind to Ixekizumab Biosimilar - Anti-IL17A mAb (cat. No.PX-TA1022) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Reviews
Il n’y a pas encore d’avis.